Delta hinders plans for RBA to taper and highlights fragility of RBNZ tightening cycle

In another volatile session in Asia as the spread of delta variant intensifies across the region, the minutes from the RBA's August meeting outlined what might cause the RBA to reconsider its decision to taper its QE program.

New Zealand

"The Board would be prepared to act in response to further bad news on the health front should that lead to a more significant setback for the economic recovery."


Lockdowns in NSW are expected to extend until the end of October when an 80% vaccination rate is reached. In response, Westpac's Chief Economist Bill Evans has cut his national GDP forecast in the September quarter from -2.2% to -2.6%; and lowered the forecast 2021 growth rate to 2.4% from 3.2%. 

Presuming Westpac's forecast is accurate, this would seem to satisfy the criteria of a "significant setback" and cause the RBA to announce a delay to its taper plan at its September meeting in three weeks, for at least three months. 

This brings us to the next big economic event, the highly anticipated RBNZ interest meeting tomorrow at midday. The RBNZ is expected to become the first major central banks to raise interest rates since the COVID-19 pandemic commenced. 

After a run of hot data noted in an article last week here, the NZ interest rate market last week was fully priced for a 25 bp hike, with a 30% chance of a 50 bp hike. However, this afternoon, a dramatic repricing has occurred following news of a New Community case of Covid in Auckland. 

A slow vaccination roll-out has left New Zealand extremely vulnerable should Covid breach its defenses. In recognition of this, the interest rate market has eased back to an 80% chance of a 25bp hike at tomorrow's meeting. 

After testing the December 1st 1.0418 low earlier this morning, the AUDNZD cross rate has spring boarded higher this afternoon above 1.0500, driven by the apparent fragility of commencing an interest rate tightening cycle in the current climate. 

While the origins of the mystery case and any spread are investigated, further gains towards 1.0600 appear likely in the short term. 


AUDNZD Daily chart


Source Tradingview. The figures stated areas of August 17th 2021. Past performance is not a reliable indicator of future performance. This report does not contain and is not to be taken as containing any financial product advice or financial product recommendation

Build your confidence risk free

More from AUD

Join our live webinars for the latest analysis and trading ideas. Register now

StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.